Clinical Trials
415
Active:17
Completed:123
Trial Phases
6 Phases
Early Phase 1:2
Phase 1:64
Phase 2:83
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (310 trials with phase data)• Click on a phase to view related trials
Not Applicable
131 (42.3%)Phase 2
83 (26.8%)Phase 1
64 (20.6%)Phase 4
17 (5.5%)Phase 3
13 (4.2%)Early Phase 1
2 (0.6%)Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study
Not Applicable
Recruiting
- Conditions
- Mild Cognitive Impairment (MCI)Alzheimer Dementia (AD)
- Interventions
- Drug: Placebo to Match Emtricitabine 200mg/Tenofovir Alafenamide 25 mg.Drug: Placebo Capsules to Match Emtricitabine Capsules, 200mg.
- First Posted Date
- 2025-10-07
- Last Posted Date
- 2025-10-07
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 48
- Registration Number
- NCT07210528
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
Dupilumab Therapy in Nephrotic Syndrome in Children
Not Applicable
Not yet recruiting
- Conditions
- Nephrotic Syndrome in ChildrenNephrotic Syndrome Steroid-Dependent
- Interventions
- Drug: PlaceboBiological: Dupilumab open label extension phaseDrug: Co-intervention of Prednisolone wean during randomised controlled phaseDrug: Co-intervention of Prednisolone wean during open label extension phase
- First Posted Date
- 2025-07-29
- Last Posted Date
- 2025-07-29
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 66
- Registration Number
- NCT07091175
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
🇸🇬KK Women's and Children's Hospital, Singapore, Singapore
HVNI vs NIPPV in Type 2 Respiratory Failure
Not Applicable
Not yet recruiting
- Conditions
- Respiratory FailureHypoxiaHypercapnia
- First Posted Date
- 2025-07-15
- Last Posted Date
- 2025-07-15
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 84
- Registration Number
- NCT07065656
Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS)
Phase 4
Recruiting
- Conditions
- CABG
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 250
- Registration Number
- NCT07031128
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
🇸🇬Singapore General Hospital, Singapore, Singapore
Screening for Early Diagnosis of Nose Cancer
Not Applicable
Recruiting
- Conditions
- Nasopharyngeal Carcinoma
- First Posted Date
- 2025-06-13
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 20000
- Registration Number
- NCT07019870
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
🇸🇬National University Polyclinics, Singapore, Singapore
- Prev
- 1
- 2
- 3
- 4
- 5
- 83
- Next
News
No news found